Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.

[1]  Z. Memish,et al.  Prevalence of MERS-CoV Nasal Carriage and Compliance With the Saudi Health Recommendations Among Pilgrims Attending the 2013 Hajj , 2014, The Journal of infectious diseases.

[2]  Z. Memish,et al.  Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  Z. Memish,et al.  Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. , 2013, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[4]  G. Dbaibo,et al.  Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial , 2013, Drugs & Aging.

[5]  Maurizio Barbeschi,et al.  Global perspectives for prevention of infectious diseases associated with mass gatherings. , 2012, The Lancet. Infectious diseases.

[6]  Z. Memish,et al.  Mass gatherings medicine. , 2012, The Lancet. Infectious diseases.

[7]  P. Dull,et al.  Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  R. Borrow.  Meningococcal disease and prevention at the Hajj. , 2009, Travel medicine and infectious disease.

[9]  M. Gooya,et al.  Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose ciprofloxacin on carriage. , 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[10]  R. Borrow,et al.  Serologic correlates of protection for evaluating the response to meningococcal vaccines , 2004, Expert review of vaccines.

[11]  G. Carlone,et al.  Serogroup B and C serum bactericidal assays. , 2001, Methods in molecular medicine.

[12]  G. Carlone,et al.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group , 1997, Clinical and diagnostic laboratory immunology.

[13]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[14]  M. Artenstein,et al.  Human immunity to the meningococcus. II. Development of natural immunity. , 1969 .